Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The UK benefits from a truly National Health Service.

Journal article

Barnes E. et al, (2022), Lancet

Cancer in sub-Saharan Africa: a Lancet Oncology Commission.

Journal article

Ngwa W. et al, (2022), Lancet Oncol

The Influence of Activin on the Tumor Microenvironment in Colon Cancer Metastasis.

Journal article

Wiley MB. et al, (2022), FASEB J, 36 Suppl 1

The Essentials of Multiomics.

Journal article

Marshall JL. et al, (2022), Oncologist, 27, 272 - 284

Immune modulation underpins the anti-cancer activity of HDAC inhibitors.

Journal article

Blaszczak W. et al, (2021), Mol Oncol, 15, 3280 - 3298

Personalising cancer medicine with prognostic markers.

Journal article

Kerr DJ. and Yang L., (2021), EBioMedicine, 72

Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer.

Journal article

Zhang N. et al, (2021), Lancet Oncol, 22, e358 - e368

Stromal composition predicts recurrence of early rectal cancer after local excision.

Journal article

Jones HJ. et al, (2021), Histopathology

Celecoxib for Stage III Colon Cancer.

Journal article

Kerr DJ. et al, (2021), JAMA, 325, 1257 - 1258

Load More